Myrtenol Reduces Orofacial Nociception and Inflammation in Mice Through p38-MAPK and Cytokine Inhibition

Myrtenol Reduces Orofacial Nociception and Inflammation in Mice Through p38-MAPK and Cytokine Inhibition

Orofacial pain is one of the commonest and most complex complaints in dentistry, greatly impairing life quality. Preclinical studies using monoterpenes have shown pharmacological potential to treat painful conditions, but the reports of the effects of myrtenol on orofacial pain and inflammation are...

Full description

Bibliographic Details
Main Authors: Janaíne P. Oliveira, Fabíula F. Abreu, José Marcos M. Bispo, Anderson R. A. Cerqueira, José Ronaldo dos Santos, Cristiane B. Correa, Soraia K. P. Costa, Enilton A. Camargo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pharmacology
Subjects:
orofacial pain
temporomandibular disorder
cytokine
mitogen-activated protein kinase
terpene
myrtenol
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.910219/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.910219/full

Similar Items